Get started

GILD

GILD is soooo frustrating ..... :(I don't know what's the deal with GILD and it's driving me crazy - the price keeps teasing my breakeven :) -- only to bounce back down - i was finally getting optimistic, thinking the curse have been lifted.. (see linked post) - not so sure now - the sentiment went back into negative territory, so did the short term momentum (check the UTO indicator) - Buy/Sell is in the "supply" zone (V.Viewer) -- or rather neutral with "no conviction"? -- we're in limbo mode with GILD for so long now. i wanted to try and sell some Covered Call against my long position into the earnings, and leverage the (earning's) volatility to improve my BE - i can't even get a good price to sell at a strike equal to or slightly above my BE .... also volatility is so low for "earning times" - so no room to have a good play there.. Grrrrr!!! should i give it more time or just give up on it ? and close it at a loss .. now i see couple of good recent moves in what seems to be attempts to finally bottom and break up - but it's just taking tooo long ! any thoughts from GILD experts?
NASDAQ:GILDLong
by RedKTrader
12
GILD - The Sleeping Giant - Trend ReversalGILD - The Sleeping Giant - Trend Reversal ___________________ ENTRY = 56.56 Double Bottom - +64 confirmation 1st Target = .236fib@72.33 2nd Target = .382fib@82.08 3rd Target = .5fib@89.97 HOLD Target = .618@97.85+ JAN22 Call Leaps Still cheap ________________________________________________________________________________________________________________________ This content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice. Good luck, happy trading and stay chill, 2degreez
NASDAQ:GILDLong
by UnknownUnicorn7216011
GILD: will it finally break the curse?GILD seems to be finally attempting to make a serious up move and breaking back into the $60's we've been holding this long position for a while, and was about to declare it a loser and close on a loss (which i totally hate!!), given the many signs of weakness GILD showed (yellow arrows), even when there was reasons to show strength (Remdesivir used on POTUS, strong market days, positive earnings ...etc) - if you have been watching GILD in the past few weeks, i'm sure you can remember these events. it was as if the market is working against GILD - every time there was some strength, sellers will just pile on it and bring the price down again! GILD went all the way down to the 2013 price levels. What changed? now for the first time we see some *positive momentum* coupled with bullish sentiment that has been up for 2 whole weeks (marked with yellow circle on the UTO on the daily) - then a relatively successful attempt today to break the down trend (been on since May) and break out from what seems to be a bottom formation What's next? for confirmation of a reversal to the upside, we need to see a close above $62, and the bulls to defend that range with commitment (price doesn't go back below $60) and drive the price up into the safe zone -- and maybe get some uptrend ?-- for me this is the last chance holding a loser - so i'm watching closely. Let me know your views.
NASDAQ:GILDLong
by RedKTrader
1
GILD Gilead upside potentialReuters Adage Capital Partners GP LLC Dissolves Share Stake In Moderna, Takes In Gilead Sciences! Reuters: Germany requests 5% of EU supply of remdesivir Germany has requested around 5% of the supply of remdesivir under a six-month European Union supply deal, its health ministry said on Monday, despite criticism of the deal due to a lack of evidence about the antiviral drug's effectiveness in treating COVID-19. A course of treatment for COVID-19 requires six doses and costs 2,070 euros ($2,407) per treatment, under the terms of the deal. The indicators are showing buy signals on every timeframe! If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:GILDLong
by TopgOptions
2
NVAX STOCKS DUMPED, DOWNTREND CONTINUESEarlier this year there was the question : How do you invest in Coronavirus vaccine stocks? Now, we have the answer : YOU DONT. Chart looking bleak, and the support lines are weak. This could be due to a few reasons: - Lack of MAINSTREAM updates - NVAX actually has no other vaccines - Market volatility due to covid and elections - Investors are seeking less riskier gains and getting out of stocks that do not look promising Other than the above, we have seen strange behavior with stocks of companies in the race. A few examples: PFE Pfizer stock not responding to numerous huge injections from government REGN Regeneron stocks hardly responding to Trump pimp GILD Gilead even FALLING after being the first company world wide to receive FDA approval for remdesivir as a treatment. AZN Astrazeneca in conjunction with Oxford has a trail candidate dead but stocks remain largely unaffected I think NVAX has potential in the long run, long term I remain bullish for the company fundamentally, but not for an investment choice right now. In fact I'd say that no vaccine stock is a good investment right now. The way the market reacts to news is too unpredictable and the future remains uncertain. Hit like if you found this insightful and helpful Thanks, Ev
NASDAQ:NVAX
by BlockTechEv
1
LONG $DGX ER run up ($MRNA $GILD $INO $SPY)see charts at www.tradingview.com $DGX Entry 120 Target 1 $125 Target 2 $130 Why DGX? FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use With Covid wave 2 on the rise, this could be a huge player. www.prnewswire.com What is DGX? Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
NYSE:DGXLong
by WallSt007
Long Gild - Covid Drug ($MRNA $GSK $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com Gild Entry $62 area Target 1 $67 Target 2 $71 stoploss $59 Why this play? Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside. What is Gild? Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Notable price upgrades Sep-30-20 Resumed Jefferies Buy $78 Sep-15-20 Upgrade Maxim Group Hold → Buy $88
NASDAQ:GILDLong
by WallSt007
3